185 related articles for article (PubMed ID: 34635134)
1. Ketogenic diet as elective treatment in patients with drug-unresponsive hyperinsulinemic hypoglycemia caused by glucokinase mutations.
Maiorana A; Caviglia S; Greco B; Alfieri P; Cumbo F; Campana C; Bernabei SM; Cusmai R; Mosca A; Dionisi-Vici C
Orphanet J Rare Dis; 2021 Oct; 16(1):424. PubMed ID: 34635134
[TBL] [Abstract][Full Text] [Related]
2. Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage.
Maiorana A; Manganozzi L; Barbetti F; Bernabei S; Gallo G; Cusmai R; Caviglia S; Dionisi-Vici C
Orphanet J Rare Dis; 2015 Sep; 10():120. PubMed ID: 26399329
[TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties.
Maiorana A; Dionisi-Vici C
J Inherit Metab Dis; 2017 Jul; 40(4):531-542. PubMed ID: 28656511
[TBL] [Abstract][Full Text] [Related]
4. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations.
Li C; Juliana CA; Yuan Y; Li M; Lu M; Chen P; Boodhansingh KE; Doliba NM; Bhatti TR; Adzick NS; Stanley CA; De León DD
Diabetes; 2023 Dec; 72(12):1809-1819. PubMed ID: 37725835
[TBL] [Abstract][Full Text] [Related]
6. Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg).
Gilis-Januszewska A; Bogusławska A; Kowalik A; Rzepka E; Soczówka K; Przybylik-Mazurek E; Głowa B; Hubalewska-Dydejczyk A
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680961
[TBL] [Abstract][Full Text] [Related]
7. Congenital hyperinsulinism: current trends in diagnosis and therapy.
Arnoux JB; Verkarre V; Saint-Martin C; Montravers F; Brassier A; Valayannopoulos V; Brunelle F; Fournet JC; Robert JJ; Aigrain Y; Bellanné-Chantelot C; de Lonlay P
Orphanet J Rare Dis; 2011 Oct; 6():63. PubMed ID: 21967988
[TBL] [Abstract][Full Text] [Related]
8. Clinical and enzymatic phenotypes in congenital hyperinsulinemic hypoglycemia due to glucokinase-activating mutations: A report of two cases and a brief overview of the literature.
Ping F; Wang Z; Xiao X
J Diabetes Investig; 2019 Nov; 10(6):1454-1462. PubMed ID: 31094068
[TBL] [Abstract][Full Text] [Related]
9. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.
Cuesta-Muñoz AL; Huopio H; Otonkoski T; Gomez-Zumaquero JM; Näntö-Salonen K; Rahier J; López-Enriquez S; García-Gimeno MA; Sanz P; Soriguer FC; Laakso M
Diabetes; 2004 Aug; 53(8):2164-8. PubMed ID: 15277402
[TBL] [Abstract][Full Text] [Related]
10. Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.
Stanley CA
J Clin Endocrinol Metab; 2016 Mar; 101(3):815-26. PubMed ID: 26908106
[TBL] [Abstract][Full Text] [Related]
11. A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy.
Adzick NS; Thornton PS; Stanley CA; Kaye RD; Ruchelli E
J Pediatr Surg; 2004 Mar; 39(3):270-5. PubMed ID: 15017536
[TBL] [Abstract][Full Text] [Related]
12. Subtotal Pancreatectomy for Congenital Hyperinsulinism: Our Experience and Review of Literature.
Redkar R; Karkera PJ; Krishnan J; Hathiramani V
Indian J Surg; 2015 Dec; 77(Suppl 3):778-82. PubMed ID: 27011456
[TBL] [Abstract][Full Text] [Related]
13. Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.
Roy K; Satapathy AK; Houhton JAL; Flanagan SE; Radha V; Mohan V; Sharma R; Jain V
Indian J Pediatr; 2019 Nov; 86(11):1051-1053. PubMed ID: 31119523
[TBL] [Abstract][Full Text] [Related]
14. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia.
Menni F; de Lonlay P; Sevin C; Touati G; Peigné C; Barbier V; Nihoul-Fékété C; Saudubray JM; Robert JJ
Pediatrics; 2001 Mar; 107(3):476-9. PubMed ID: 11230585
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia.
Hallböök T; Sjölander A; Åmark P; Miranda M; Bjurulf B; Dahlin M
Eur J Paediatr Neurol; 2015 Jan; 19(1):29-36. PubMed ID: 25457511
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases.
Lord K; Dzata E; Snider KE; Gallagher PR; De León DD
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1786-9. PubMed ID: 24057290
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children.
Adzick NS; De Leon DD; States LJ; Lord K; Bhatti TR; Becker SA; Stanley CA
J Pediatr Surg; 2019 Jan; 54(1):27-32. PubMed ID: 30343978
[TBL] [Abstract][Full Text] [Related]
18. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism.
Snider KE; Becker S; Boyajian L; Shyng SL; MacMullen C; Hughes N; Ganapathy K; Bhatti T; Stanley CA; Ganguly A
J Clin Endocrinol Metab; 2013 Feb; 98(2):E355-63. PubMed ID: 23275527
[TBL] [Abstract][Full Text] [Related]
19. Ketogenic diet effects on neurobehavioral development of children with intractable epilepsy: A prospective study.
Zhu D; Wang M; Wang J; Yuan J; Niu G; Zhang G; Sun L; Xiong H; Xie M; Zhao Y
Epilepsy Behav; 2016 Feb; 55():87-91. PubMed ID: 26773676
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of GLUT1 deficiency syndrome in patients treated with ketogenic diet.
Ramm-Pettersen A; Nakken KO; Haavardsholm KC; Selmer KK
Epilepsy Behav; 2014 Mar; 32():76-8. PubMed ID: 24508593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]